Nanobiotechnology and Nanotoxicology are two fields that deal with the interaction of nanomaterials with biological systems, but they approach this interaction from different perspectives.
Nanobiotechnology is the use of nanotechnology in the fields of biology, medicine, and biotechnology. It involves the development of nanoscale materials and devices for use in biological systems, such as drug delivery systems, biosensors, and tissue engineering scaffolds. Nanobiotechnology is a rapidly growing field, with potential applications in areas such as cancer diagnosis and treatment, regenerative medicine, and personalized medicine.
Nanotoxicology, on the other hand, is the study of the potential toxicity of nanomaterials to biological systems. Nanomaterials have unique physicochemical properties that can cause them to interact with biological systems in ways that are different from traditional chemicals. As a result, nanotoxicology is concerned with understanding the potential hazards of nanomaterials and developing safe practices for their use. This includes studying the effects of nanomaterials on human health and the environment, as well as developing methods for risk assessment and mitigation.
By studying the interactions between nanomaterials and biological systems, researchers can develop new nanobiotechnology products that are safe and effective, while minimizing the potential risks to human health and the environment. This requires a multidisciplinary approach, involving experts in fields such as chemistry, biology, medicine, and engineering, as well as collaboration between academia, industry, and regulatory agencies.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
